Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.

Angle Market & Company News

27.10.2020 18:28 Angle PLC Result of Placing & Notice of General Meeting RNS
27.10.2020 09:58 Angle PLC Angle to raise up to £20m through discounted equity placing to fund ongoing operations, expansion SMW
27.10.2020 07:00 Angle PLC Accelerated bookbuild to raise up to RNS
20.10.2020 09:52 Angle PLC Angle's parsortix system gets nod for substantive review in US SMW
20.10.2020 07:00 Angle PLC Submission accepted by FDA for substantive review RNS
28.09.2020 07:47 Angle PLC Angle seeks clearance for liquid biopsy system in US SMW
28.09.2020 07:00 Angle PLC Issue of LTIP Options and Share Options RNS
28.09.2020 07:00 Angle PLC ANGLE announces completion of FDA submission RNS
23.09.2020 14:12 Angle PLC Angle says technology used in breakthrough University of Basel cancer research SMW
23.09.2020 07:00 Angle PLC Potential treatment strategy to limit metastasis RNS
11.09.2020 15:35 Angle PLC Holding(s) in Company RNS
11.09.2020 15:30 Angle PLC Holding(s) in Company RNS
02.09.2020 13:49 Angle PLC Notification of Interim Results and Webcast RNS
02.09.2020 10:00 Angle PLC Holding(s) in Company RNS
27.08.2020 15:13 Angle PLC Result of 2020 Annual General Meeting RNS
18.08.2020 09:30 Angle PLC Holding(s) in Company RNS
14.08.2020 08:26 Angle PLC Angle hails further proof showing potential of Parsortix to assess response to immunotherapy SMW
14.08.2020 07:00 Angle PLC Parsortix use to assess response to immunotherapy RNS
06.08.2020 12:20 Angle PLC Holding(s) in Company RNS
05.08.2020 07:00 Angle PLC Notice of AGM and Posting of Annual Report RNS
20.07.2020 14:23 Angle PLC Angle welcomes university study showing effectiveness of its technology SMW
20.07.2020 07:00 Angle PLC Study: Parsortix use in metastatic breast cancer RNS
08.07.2020 17:35 Angle PLC Holding(s) in Company RNS
08.07.2020 17:30 Angle PLC Holding(s) in Company RNS
08.07.2020 17:30 Angle PLC Holding(s) in Company RNS
25.06.2020 10:02 Angle PLC Angle narrows losses; eyes FDA application for Parsortix system in Q3 SMW
25.06.2020 07:00 Angle PLC Preliminary Results RNS
22.06.2020 14:06 Angle PLC Angle recommences blood donations for liquid biopsy studies SMW
22.06.2020 07:00 Angle PLC Blood donations recommenced for FDA studies RNS
29.05.2020 07:00 Angle PLC Notice of Results RNS
12.05.2020 07:00 Angle PLC CTC potential as biomarker in MET inhibitor trials RNS
04.05.2020 07:00 Angle PLC Leading cancer centre publishes Parsortix workflow RNS
28.04.2020 07:00 Angle PLC Business Update RNS
17.04.2020 14:52 Angle PLC Angle biopsy technology demonstrated in head and neck cancer SMW
17.04.2020 07:00 Angle PLC Parsortix performance in head and neck cancer RNS
31.03.2020 07:00 Angle PLC COVID-19 BUSINESS IMPACT UPDATE RNS
03.03.2020 07:00 Angle PLC Assessing risk of brain metastasis in lung cancer RNS
27.02.2020 07:00 Angle PLC Parsortix outperforms other CTC systems in RCC RNS
25.02.2020 07:00 Angle PLC ANGLE announce Tri-Con presentation with BioView RNS
17.02.2020 07:00 Angle PLC Data demonstrates key advantages of Parsortix RNS
11.02.2020 10:09 Angle PLC Angle says new study demonstrates potential for Parsortix in melanoma prognosis, treatment response SMW
11.02.2020 07:00 Angle PLC Study demonstrates Parsortix potential in melanoma RNS
03.02.2020 09:10 Angle PLC Issue of Equity RNS
30.01.2020 10:07 Angle PLC Angle losses widen as costs swell on spending to develop liquid biopsy system SMW
30.01.2020 07:00 Angle PLC Interim Results RNS
30.01.2020 07:00 Angle PLC Change of accounting reference date RNS
22.01.2020 07:00 Angle PLC Successful face-to-face meeting with FDA RNS
08.01.2020 12:33 Angle PLC Notice of Results RNS
23.12.2019 09:55 Angle PLC Issue of Equity RNS
07.11.2019 07:00 Angle PLC Cancer centre shows Parsortix use in melanoma RNS
Showing 1 to 50 of 878